U.K. Reconsidering Plan to Buy Astra Covid Antibody Drug
- U.K. government said last year it had bought one million doses
- Role of antibody cocktails in U.K. strategy undecided: source
This article is for subscribers only.
The U.K. has reconsidered plans to buy one million doses of AstraZeneca Plc’s Covid-19 antibody treatment, according to two people with knowledge of the situation.
While the first data from the treatment’s trials are expected in the coming weeks, the U.K. has no orders for it and is still evaluating the role antibody cocktails may play in Britain’s response to the pandemic, according to one of the people, who didn’t want to be identified because details of the discussions are private. Alok Sharma, the U.K.’s former business secretary, said in November that the country had procured the doses pending trial results.